Werewolf Therapeutics Inc (HOWL)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current HOWL market cap is 58M. The company's latest EPS is USD -0.8385 and P/E is -1.60.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.9M | 1.5M | 742k | 1.14M | 0 |
| Operating Income | -9.25M | -12.96M | -17.16M | -18.96M | -17.12M |
| Net Income | -8.29M | -12M | -16.19M | -17.25M | -16.67M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 16.4M | 19.94M |
| Operating Income | -9.94M | -22.4M | -50.09M | -56.06M | -40.5M |
| Net Income | -18.23M | -28.22M | -201.93M | -53.81M | -37.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 176.39M | 174.83M | 177.6M | 153.7M | 140.04M |
| Total Liabilities | 63.94M | 63.46M | 60.01M | 49.69M | 50.66M |
| Total Equity | 112.44M | 111.37M | 117.59M | 104.02M | 89.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.68M | 96.4M | 179.25M | 160.25M | 174.83M |
| Total Liabilities | 11.91M | 7.18M | 26.46M | 37.91M | 63.46M |
| Total Equity | -24.3M | -51.86M | 152.79M | 122.34M | 111.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28.03M | -32.61M | -15.3M | -29.47M | -41.94M |
| Investing | -571k | -769k | -111k | -128k | -131k |
| Financing | 49.36M | 58.43M | 20.26M | 10.54M | 10.53M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.54M | -18.62M | -42.88M | -40.6M | -32.61M |
| Investing | -266k | -560k | -498k | -3.61M | -769k |
| Financing | 21.91M | 93.86M | 109.43M | 15.91M | 58.43M |
| Market Cap | 58M |
| Price to Earnings Ratio | -1.60 |
| Price to Sales Ratio | 2.99 |
| Price to Cash Ratio | 0.44 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 44.56M |
| Average Volume (1 week) | 160.67k |
| Average Volume (1 Month) | 251.3k |
| 52 Week Change | -82.46% |
| 52 Week High | 8.1939 |
| 52 Week Low | 1.26 |
| Spread (Intraday) | 0.07 (5.11%) |
| Company Name | Werewolf Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://werewolftx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
